The news is by your side.

- Advertisement -

Nigerian Universities’ Scientists Discover COVID-19 Vaccine

Nigerian Universities’ Scientists, working under the aegis of COVID-19 Research Group, on Friday announced the discovery of a vaccine for the prevention of Coronavirus (COVID-19) pandemic.

 

Addressing a news conference on Friday at Adeleke University, Ede, in Osun, Dr Oladipo Kolawole, Leader of the team, said the vaccine was being developed locally in Africa for Africans.

 

Kolawole, a Specialist in Medical Virology, Immunology and Bioinformatics, at Adeleke University, Ede, said the study was funded by the Trinity Immunodeficient Laboratory and Helix Biogen Consult, Ogbomosho, to the tune of about N7.8 million.

ALSO READ  MALARIA: Kwara To Engage 5,000 Adhoc Workers' ,Gets N2.3m Insecticide Nets To Save Women, Children

 

- Advertisement -

- Advertisement -

He said the group had been working extensively by exploring the SARS-CoV-2 genome from African countries to select the best possible potential vaccine candidates.

 

On how soon the unnamed vaccine would be unveiled to the public, Kolawole said that it would take a minimum of 18 months after approvals by medical authorities.

 

- Advertisement -

Also, Prof. Solomon Adebola, the Acting Vice-Chancellor of the university, said the university was poised to assist in the funding of the research with a view to bringing the vaccine to the limelight.

 

ALSO READ  LASG Shutdown 40 Health Facilities In Six Months , Vows To Combat Quackery 

Commenting, Prof. Julius Oloke, the Head, Coordinating Unit of the Research Group and Vice-Chancellor of Precious Cornerstone University, Ibadan, said the vaccine was real.

 

“The vaccine is real. We have validated it severally. It is targeted at Africans, but will also work for other races.

 

“It will work. It cannot be faked. This is a result of the determination. It took a lot of scientific efforts.

 

“The population of those that need vaccines is more than those that need drugs. That is why the research focused on a vaccine.”

Comments are closed.